FDA Approves Unknown Drug — GLAXOSMITHKLINE

# FDA Approves GlaxoSmithKline Drug (NDA 018342) GlaxoSmithKline has received FDA approval for a new drug application, marking an expansion of the company's pharmaceutical portfolio. The approval positions GlaxoSmithKline to capture additional market share in its therapeutic category and strengthen its competitive standing in the broader pharmaceutical market.